Regulatory status notice
BPC-157
Public promotion and availability are paused during review.
Education only
This category is not currently offered or promoted by LifeSpann
BPC-157 is part of, or contains an ingredient from, the FDA Pharmacy Compounding Advisory Committee agenda for July 23-24, 2026. LifeSpann is holding public promotion while the committee process, final FDA status, evidence, and pharmacy availability are reviewed by a human decision-maker.
This preserved URL is a status notice only. It is not an offer to prescribe, compound, sell, or distribute a product, and it does not establish safety, effectiveness, availability, or suitability for any patient.